Search filters

List of works by Stephen Stahl

15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL

scientific article

A Horse of a Different Color: How Formulation Influences Medication Effects ⬇️

scientific article published on June 1, 2012

A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor

scientific article

A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder

scientific article

A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial

scientific article published on August 2010

A proposal for an updated neuropsychopharmacological nomenclature

scientific article published on 18 September 2013

A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

scientific article

A social history of serious mental illness

scientific article published on 12 May 2020

A successful antipsychotic combination trial. Quo Vadis?

scientific article published in October 2004

A survey of national trends in psychiatric patients found incompetent to stand trial: reasons for the reinstitutionalization of people with serious mental illness in the United States

scientific article published on 09 January 2020

Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial

scientific article

Analysis of the rate of improvement of specific psychic and somatic symptoms of general anxiety disorder during long-term treatment with venlafaxine ER.

scientific article published in September 2007

Antagonist treatment is just as effective as replacement therapy for opioid addiction but neither is used often enough

scientific article published on 01 April 2018

Anticonvulsants and the relief of chronic pain: pregabalin and gabapentin as alpha(2)delta ligands at voltage-gated calcium channels

scientific article

Anticonvulsants as anxiolytics, part 1: tiagabine and other anticonvulsants with actions on GABA.

scientific article published on March 2004

Anticonvulsants as anxiolytics, part 2: Pregabalin and gabapentin as alpha(2)delta ligands at voltage-gated calcium channels

scientific article published in April 2004

Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels.

scientific article

Antidepressant treatment of psychotic major depression: potential role of the sigma receptor

scientific article

Antidepressants and somatic symptoms: therapeutic actions are expanding beyond affective spectrum disorders to functional somatic syndromes

scientific article published in July 2003

Antipsychotic Drug Development ⬇️

scientific article published on January 1, 2010

Antipsychotic polypharmacy: never say never, but never say always ⬇️

scientific article published on 01 May 2012

Antipsychotic polypharmacy: squandering precious resources?

scientific article published on 01 February 2002

Applying the principles of adult learning to the teaching of psychopharmacology: audience response systems

scientific article published on August 2009

Applying the principles of adult learning to the teaching of psychopharmacology: overview and finding the focus

scientific article

Applying the principles of adult learning to the teaching of psychopharmacology: storyboarding a presentation and the rule of small multiples.

scientific article published on June 2009

At long last, long-lasting psychiatric medications: an overview of controlled-release technologies.

scientific article published in April 2003

Atypical antipsychotics: matching receptor profile to individual patient's clinical profile

scientific article published in October 2004

Awakening to the psychopharmacology of sleep and arousal: novel neurotransmitters and wake-promoting drugs

scientific article published in June 2002

Balancing the pendulum: rethinking the role of institutionalization in the treatment of serious mental illness

scientific article published on 01 April 2020

Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate

scientific article published on 01 June 2018

Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia.

scientific article published in April 2007

Bottlenecks in the development of topical analgesics: molecule, formulation, dose-finding, and phase III design

scientific article published on 20 March 2017

Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder.

scientific article published on January 2003

Brainstorms: symptoms and circuits, part 2: anxiety disorders

scientific article

Breaking down long-term chronic aggression within a forensic hospital system

scientific article published on 01 April 2020

Building a better antipsychotic: receptor targets for the treatment of multiple symptom dimensions of schizophrenia

scientific article published on January 2009

California State Hospital Violence Assessment and Treatment (Cal-VAT) guideline

scientific article published on October 2014

California State Hospital Violence Assessment and Treatment (Cal-VAT) guidelines

scientific article published in October 2014

Can psychopharmacologic treatments that relieve symptoms also prevent disease progression?

scientific article published in November 2002

Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data

scientific article published on 12 February 2020

Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies

scientific article published on 02 October 2019

Ciprofloxacin and Clozapine: A Potentially Fatal but Underappreciated Interaction.

scientific article published on 30 October 2016

Circuits of sexual desire in hypoactive sexual desire disorder

scientific article published on May 2010

Classifying psychotropic drugs by mode of action and not by target disorder ⬇️

scientific article published on June 1, 2013

Clinical management of major depressive disorder

scientific article published on 01 November 2009

Clozapine: is now the time for more clinicians to adopt this orphan?

scientific article published in August 2014

Co-Use of Donepezil and Hypnotics Among Alzheimer's Disease Patients Living in the Community

scientific article published on April 1, 2003

Combining antidepressant therapies from the initiation of treatment: a paradigm shift for major depression

scientific article

Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression

scientific article

Comparing pharmacologic mechanism of action for the vesicular monoamine transporter 2 (VMAT2) inhibitors valbenazine and deutetrabenazine in treating tardive dyskinesia: does one have advantages over the other?

scientific article published on 01 August 2018

Conditions of life and death of psychiatric patients in France during World War II: euthanasia or collateral casualties?

scientific article published on 30 October 2017

Controversies in treating bipolar depression ⬇️

scientific article published on August 1, 2013

Crisis in army psychopharmacology and mental health care at Fort Hood

scientific article published in December 2009

Dazzled by the dominions of dopamine: clinical roles of D3, D2, and D1 receptors

scientific article

Deconstructing psychiatric disorders, Part 1. Genotypes, symptom phenotypes, and endophenotypes.

scientific article published in September 2003

Deconstructing psychiatric disorders, part 2: An emerging, neurobiologically based therapeutic strategy for the modern psychopharmacologist

scientific article published in October 2003

Deconstructing violence as a medical syndrome: mapping psychotic, impulsive, and predatory subtypes to malfunctioning brain circuits

scientific article published in October 2014

Deuterium Tetrabenazine for Tardive Dyskinesia

scientific article published in January 2018

Dextromethorphan-quinidine-responsive pseudobulbar affect (PBA): psychopharmacological model for wide-ranging disorders of emotional expression?

scientific article published in December 2016

Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity

scientific article published on 01 October 2019

Dextromethorphan/bupropion: a novel oral NMDA (N-methyl-d-aspartate) receptor antagonist with multimodal activity-Addendum

scientific article published on 27 November 2019

Differences in mechanism of action between current and future antidepressants

scientific article published on January 1, 2003

Do dopamine partial agonists have partial efficacy as antipsychotics?

scientific article published in April 2008

Does a "whiff" of mania in a major depressive episode shift treatment from a classical antidepressant to an atypical/second-generation antipsychotic?

scientific article published on 12 September 2017

Does depression hurt?

scientific article published on April 2002

Does treating hearing loss prevent or slow the progress of dementia? Hearing is not all in the ears, but who's listening?

scientific article published on 5 April 2017

Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder.

scientific article published in September 2002

Dosing atypical antipsychotics

scientific article published on May 2008

Drug combinations for bipolar spectrum disorders: evidence-based prescribing or prescribing-based evidence?

scientific article published in October 2004

Drug information update. Unconventional treatment strategies for schizophrenia: polypharmacy and heroic dosing

scientific article

Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes

scientific article published in October 2017

Economics of decriminalizing mental illness: when doing the right thing costs less

scientific article published on 08 January 2020

Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial

scientific article

Effectiveness of ipsapirone, a 5-HT-1A partial agonist, in major depressive disorder: support for the role of 5-HT-1A receptors in the mechanism of action of serotonergic antidepressants

scientific article published in July 1998

Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone, olanzapine, or placebo: a 6-month, open-label, extension study.

scientific article published on 13 March 2013

Effects of reboxetine on anxiety, agitation, and insomnia: results of a pooled evaluation of randomized clinical trials

scientific article published in August 2002

Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial

scientific article published in April 2010

Efficacy of Bupropion and the Selective Serotonin Reuptake Inhibitors in the Treatment of Major Depressive Disorder With High Levels of Anxiety (Anxious Depression)

scholarly article by George I. Papakostas et al published 15 August 2008 in The Journal of Clinical Psychiatry

Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies

scientific article

Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials

scientific article

Emerging guidelines for the use of antipsychotic polypharmacy ⬇️

scientific article published on February 26, 2013

Emotion processing, the amygdala, and outcome in schizophrenia

scientific article

Enhancing outcomes from major depression: using antidepressant combination therapies with multifunctional pharmacologic mechanisms from the initiation of treatment.

scientific article published in February 2010

Epigenetics and methylomics in psychiatry

scientific article published in September 2009

Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.

scientific article

Evil, terrorism, and psychiatry

scientific article

Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease

scientific article published in April 2004

Expert Consensus on Screening and Assessment of Cognition in Psychiatry

scientific article published on 15 January 2019

Fibromyalgia--pathways and neurotransmitters

scientific article published in June 2009

Finding what you are not looking for: strategies for developing novel treatments in psychiatry

scientific article published on January 2006

Flibanserin - the female Viagra?

scientific article published on 24 April 2017

Focus on antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence?

scientific article published on 25 February 2004

Fooling mother nature: epigenetics and novel treatments for psychiatric disorders.

scientific article published on June 2010

Forensic focused treatment planning: a new standard for forensic mental health systems

scientific article published on 24 March 2015

Four-Dimensional 15N-Separated NOESY of Slowly Tumbling Perdeuterated 15N-Enriched Proteins. Application to HIV-1 Nef

article

Functional psychopharmacology is the way to go in pharmacotherapy for psychiatric disorders ⬇️

scientific article published on December 1, 2010

Genetic Data Supporting the NMDA Glutamate Receptor Hypothesis for Schizophrenia ⬇️

scientific article published on January 1, 2012

Glutamate Neurocircuitry: Theoretical Underpinnings in Schizophrenia ⬇️

scientific article published on November 26, 2012

Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus

scientific article published on 01 December 2018

Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus

scientific article published on 01 October 2019

Guidelines for the recognition and management of mixed depression

scientific article

Here today and not gone tomorrow: the curse of chronic pain and other central sensitization syndromes

scientific article published on 01 August 2003

High-cost use of second-generation antipsychotics under California's Medicaid program

scientific article

How and When to Treat the Most Common Adverse-Effects of Antipsychotics: Expert Review From Research to Clinical Practice

scientific article published on 11 December 2020

How to dose a psychotropic drug: beyond therapeutic drug monitoring to genotyping the patient ⬇️

scientific article published on September 29, 2010

Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review

scientific article

Illustrating the Circuits of Sexual Desire ⬇️

scientific article published on September 1, 2010

Iloperidone, asenapine and lurasidone: a primer on their current status ⬇️

scientific article published on July 31, 2012

Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder

scientific article

Independent actions on fear circuits may lead to therapeutic synergy for anxiety when combining serotonergic and GABAergic agents

scientific article published in October 2002

Introduction: optimizing wakefulness in patients with fatigue and executive dysfunction.

scientific article published in January 2003

Inverse agonists - What do they mean for psychiatry?

scientific article

Is impulsive violence an addiction? The Habit Hypothesis

scientific article published on 27 April 2015

Is psychopharmacologic "inoculation" effective in preventing posttraumatic stress disorder?

scientific article published in January 2005

Kick-Off Editorial for 2017: CNS Spectrums Is on the Move

scientific article published on 01 February 2017

L-methylfolate: a vitamin for your monoamines.

scientific article

Last episode psychosis

scientific article published in June 2009

Long-acting injectable antipsychotics: shall the last be first?

scientific article published on 01 February 2014

Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability

scientific article published on September 2015

Mechanism of action of agomelatine: a novel antidepressant exploiting synergy between monoaminergic and melatonergic properties

scientific article

Mechanism of action of alpha 2A-adrenergic agonists in attention-deficit/hyperactivity disorder with or without oppositional symptoms

scientific article published in March 2010

Mechanism of action of alpha2delta ligands: voltage sensitive calcium channel (VSCC) modulators.

scientific article

Mechanism of action of brexpiprazole: comparison with aripiprazole

scientific article published in February 2016

Mechanism of action of cariprazine

scientific article published on 9 March 2016

Mechanism of action of dextromethorphan/quinidine:comparison with ketamine

scientific article published in October 2013

Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder

scientific article

Mechanism of action of ketamine

scientific article published in August 2013

Mechanism of action of pimavanserin in Parkinson's disease psychosis: targeting serotonin 5HT2A and 5HT2C receptors

scientific article published in August 2016

Mechanism of action of stimulants in attention-deficit/hyperactivity disorder

scientific article published on January 2010

Mechanism of action of suvorexant

scientific article

Mechanism of action of tasimelteon in non-24 sleep-wake syndrome: treatment for a circadian rhythm disorder in blind patients

scientific article

Mechanism of action of the SPARI vilazodone: serotonin 1A partial agonist and reuptake inhibitor

scientific article

Mechanism of action of trazodone: a multifunctional drug

scientific article published on October 2009

Mechanism of action of vesicular monoamine transporter 2 (VMAT2) inhibitors in tardive dyskinesia: reducing dopamine leads to less "go" and more "stop" from the motor striatum for robust therapeutic effects

scientific article published on 18 December 2017

Mechanism of action of voltage sensitive sodium channel modulators

scientific article published on 01 July 2004

Mental energy: plausible neurological mechanisms and emerging research on the effects of natural dietary compounds

scientific article published on 31 October 2019

Methylated spirits: epigenetic hypotheses of psychiatric disorders.

scientific article published in April 2010

Methylenedioxymethamphetamine (MDMA)

article

Mirror, mirror on the wall, which enantiomer is fairest of them all?

scientific article published on 01 August 2002

Mixed mood states: Baffled, bewildered, befuddled and bemused

scientific article published on 11 May 2019

Mixed-up about how to diagnose and treat mixed features in major depressive episodes

scientific article published on 8 March 2017

Mixed-up about how to diagnose and treat mixed features in major depressive episodes - CORRIGENDUM.

scientific article published on 22 January 2018

Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): actions at serotonin receptors may enhance downstream release of four pro-cognitive neurotransmitters

scientific article

Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine

scientific article

Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): enhancing serotonin release by combining serotonin (5HT) transporter inhibition with actions at 5HT receptors (5HT1A, 5HT1B, 5HT1D, 5HT7 receptors).

scientific article

Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): modifying serotonin's downstream effects on glutamate and GABA (gamma amino butyric acid) release

scientific article

Modulating the serotonin system in the treatment of major depressive disorder

scientific article published on December 2014

Modulating the serotonin system in the treatment of major depressive disorder-ERRATUM.

scientific article

Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants

scientific article

Multifunctional Pharmacology of Flibanserin: Possible Mechanism of Therapeutic Action in Hypoactive Sexual Desire Disorder ⬇️

scientific article published on September 14, 2010

Multifunctional drugs: a novel concept for psychopharmacology

scientific article

Neuronal traffic signals in tardive dyskinesia: not enough "stop" in the motor striatum

scientific article published in December 2017

Neurotransmission of cognition, part 1, Dopamine is a hitchhiker in frontal cortex: norepinephrine transporters regulate dopamine.

scientific article published in January 2003

Neurotransmission of cognition, part 2. Selective NRIs are smart drugs: exploiting regionally selective actions on both dopamine and norepinephrine to enhance cognition

scientific article published in February 2003

Neurotransmission of cognition, part 3. Mechanism of action of selective NRIs: both dopamine and norepinephrine increase in prefrontal cortex

scientific article published on March 1, 2003

New Medications for Neuropsychiatric Disorders

scientific article published on 08 April 2020

New hope for Alzheimer's dementia as prospects for disease modification fade: symptomatic treatments for agitation and psychosis

scientific article published on 01 October 2018

Norepinephrine and dopamine regulate signals and noise in the prefrontal cortex.

scientific article published in May 2009

Novel agents in development for the treatment of depression

scientific article

Novel challenges to psychiatry from a changing world

scientific article published on 27 January 2020

Novel mechanism of antidepressant action: norepinephrine and dopamine disinhibition (NDDI) plus melatonergic agonism

scientific article

Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent

scientific article

Novel therapeutics for schizophrenia: targeting glycine modulation of NMDA glutamate receptors.

scientific article published on June 2007

Off-label prescribing: best practice or malpractice?

scientific article published in February 2013

Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression ⬇️

scientific article published on September 1, 2012

Optimizing Outcomes in Schizophrenia: Long-acting Depots and Long-term Treatment ⬇️

scientific article published on November 1, 2012

Overview of trends in modern psychopharmacology.

scientific article published on February 2007

Parkinson's disease psychosis as a serotonin-dopamine imbalance syndrome

scientific article published in October 2016

Personalized medicine, pharmacogenomics, and the practice of psychiatry: on the threshold of predictive therapeutics in psychopharmacology?

scientific article published in February 2008

Pharmacologic Treatment of Mixed States

scientific article published on 03 December 2019

Pharmacotherapy of cognitive deficits in schizophrenia

scientific article

Placebo response rate is ruining drug development in psychiatry: why is this happening and what can we do about it?

scientific article published on 01 February 2019

Play it Again: The Master Psychopharmacology Program as an Example of Interval Learning in Bite-Sized Portions.

scientific article published in August 2010

Positive findings for negative symptoms of schizophrenia: no longer untreatable?

scientific article published in November 2006

Practical guide for prescribing MAOIs: debunking myths and removing barriers ⬇️

scientific article published on March 1, 2012

Precision and personalized assessment, diagnosis and treatment in psychiatry

scientific article published on 31 March 2020

Preemptive analgesia: is pain less costly when you pre-pay for it?

scientific article published on 01 December 2004

Prolonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy

scientific article published on 9 April 2015

Prophylactic antipsychotics: do they keep you from catching schizophrenia?

scientific article published on 01 November 2004

Psychiatric Pharmacogenomics: How to Integrate into Clinical Practice

scientific article

Psychiatric stress testing: novel strategy for translational psychopharmacology

scientific article published on June 2010

Psychopharmacology and ethnicity: A comparative study on Senegalese and Italian men

scientific article published on 23 April 2019

Psychopharmacology of Persistent Violence and Aggression

scientific article published on December 2016

Psychopharmacology of anticonvulsants: do all anticonvulsants have the same mechanism of action?

scientific article published in February 2004

Psychopharmacology of anticonvulsants: levetiracetam as a synaptic vesicle protein modulator.

scientific article published in September 2004

Psychopharmacology of wakefulness: pathways and neurotransmitters.

scientific article published in July 2002

Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation

scientific article published on 18 June 2007

Risperidone and paroxetine given singly and in combination for bipolar depression.

scientific article published in December 2004

Role of α1 adrenergic antagonism in the mechanism of action of iloperidone: reducing extrapyramidal symptoms

scientific article published in December 2013

SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants

scholarly article by Stephen Stahl et al published September 2005 in C N S Spectrums

SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants

scientific article

Selective actions on sleep or anxiety by exploiting GABA-A/benzodiazepine receptor subtypes.

scientific article

Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines

scientific article published on December 2008

Selectivity of SSRIs: individualising patient care through rational treatment choices.

scientific article

Serotonergic Drugs for Depression and Beyond ⬇️

scientific article published on May 1, 2013

Serotonin and Love: Supporting Evidence From a Patient Suffering From Obsessive-Compulsive Disorder

scientific article published on 20 November 2017

Some relationships among assessments of depression

scientific article published in December 2002

Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.

scientific article

Symptoms and circuits, part 1: major depressive disorder

scientific article published on November 2003

Symptoms and circuits, part 3: schizophrenia.

scientific article published on January 2004

TRPV1 Antagonists and Chronic Pain: Beyond Thermal Perception

scientific article published on 02 February 2012

Tailoring treatment of depression for women across the reproductive lifecycle: the importance of pregnancy, vasomotor symptoms, and other estrogen-related events in psychopharmacology.

scientific article

Targeting circuits of sexual desire as a treatment strategy for hypoactive sexual desire disorder

scientific article published on July 2010

Teaching psychopharmacology: what works and what doesn't

scientific article published in February 2008

Temperature regulation in depression: functional 5HT1A receptor adaptation differentiates antidepressant response

scientific article published on 26 April 2006

The International Journal of Neuropsychopharmacology

scientific article

The Mechanism of Drug-induced Akathsia

scientific article published on January 15, 2011

The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities? ⬇️

scientific article published on 02 May 2013

The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.

scientific article

The genetics of schizophrenia converge upon the NMDA glutamate receptor.

scientific article published in August 2007

The last Diagnostic and Statistical Manual (DSM): replacing our symptom-based diagnoses with a brain circuit-based classification of mental illnesses ⬇️

scientific article published on April 1, 2013

The many faces of fatigue in major depressive disorder

scientific article published on 14 October 2004

The metabolic syndrome: psychopharmacologists should weigh the evidence for weighing the patient

scientific article published on 01 December 2002

The potential role of a corticotropin-releasing factor receptor-1 antagonist in psychiatric disorders.

scientific article published on June 2008

The prefrontal cortex is out of tune in attention-deficit/hyperactivity disorder

scientific article published in July 2009

The psychopharmacology of energy and fatigue.

scientific article published on January 2002

The psychopharmacology of painful physical symptoms in depression.

scientific article published in May 2002

The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice

scientific article published on January 2003

The relevance of COVID-19 pandemic to psychiatry

scientific article published on 01 June 2020

The serotonin-7 receptor as a novel therapeutic target

scientific article published on November 2010

The sigma enigma: can sigma receptors provide a novel target for disorders of mood and cognition?

scientific article published in November 2008

The tyranny of the majority and the interchangeability of drugs ⬇️

scientific article published on 01 January 2013

The ups and downs of novel antiemetic drugs, part 1: substance P, 5-HT, and the neuropharmacology of vomiting.

scientific article published in May 2003

The ups and downs of novel antiemetic drugs, part 2: an illustration

scientific article

The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies

scientific article published on 16 October 2012

Toward convergence in the medication treatment of bipolar disorder and schizophrenia

scientific article

Translating from neuroscience to psychiatry (and back translating from psychiatry to neuroscience)

scientific article published on 01 August 2013

Treat the treatable: a comprehensive and optimistic approach to treating psychiatric violence

scientific article published in June 2015

Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy

scientific article published on 14 August 2014

Treatment Strategies for Dosing the Second Generation Antipsychotics ⬇️

scientific article published on April 1, 2011

Understanding pain in depression

scientific article published in October 2004

Using neuroscience for naming psychotropic drugs

scientific article published on 01 June 2016

Vasomotor symptoms and depression in women, part 2. Treatments that cause remission and prevent relapses of major depressive episodes overlap with treatments for vasomotor symptoms

scientific article

Vasomotor symptoms and depression in women, part I. Role of vasomotor symptoms in signaling the onset or relapse of a major depressive episode.

scientific article published in January 2009

Vilazodone: a brief pharmacological and clinical review of the novel serotonin partial agonist and reuptake inhibitor

scientific article published on June 2011

Why psychiatrists should not ignore pain in their patients--focus on fibromyalgia?

scientific article published in June 2009

Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia? ⬇️

scientific article published on February 15, 2011

“Meta-guidelines” for the management of patients with schizophrenia

scientific article published on June 2013

Paulina is supported by:

About Paulina

Help